SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-05-25 17:22
Tx date 2022-05-25 		$ASP
Acerus Pharmaceuticals Corporation 		Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$31,350
+100 vol
$313.50 each 		2,500
Filed 2022-05-20 16:19
Tx date 2022-05-20 		$ASP
Acerus Pharmaceuticals Corporation 		Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$686.00
+200 vol
$3.43 each 		2,400
Filed 2022-05-19 14:49
Tx date 2022-05-19 		$ASP
Acerus Pharmaceuticals Corporation 		Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$363.50
+100 vol
$3.63 each 		2,200
Filed 2022-05-19 14:48
Tx date 2022-05-18 		$ASP
Acerus Pharmaceuticals Corporation 		Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$388.00
+100 vol
$3.88 each 		2,100
Filed 2022-05-19 14:45
Tx date 2022-05-12 		$ASP
Acerus Pharmaceuticals Corporation 		Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,594
+2,000 vol
$3.80 each 		2,000
Filed 2022-05-12 11:51
Tx date 2022-05-12 		$ASP
Acerus Pharmaceuticals Corporation 		Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,594
+2,000 vol
$3.80 each
Filed 2022-05-12 11:51
Tx date 2022-05-12 		$ASP
Acerus Pharmaceuticals Corporation 		Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,594
+2,000 vol
$3.80 each 		2,000
Filed 2022-05-12 11:51
Tx date 2022-03-07 		$ASP
Acerus Pharmaceuticals Corporation 		Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-11 14:56
Tx date 2022-05-11 		$ASP
Acerus Pharmaceuticals Corporation 		Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,260
+500 vol
$4.52 each 		79,482
Filed 2022-05-11 14:53
Tx date 2022-05-11 		$ASP
Acerus Pharmaceuticals Corporation 		Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$466.00
+100 vol
$4.66 each 		2,506
Filed 2022-05-11 14:53
Tx date 2022-05-11 		$ASP
Acerus Pharmaceuticals Corporation 		Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$453.00
+100 vol
$4.53 each 		2,406
Filed 2022-05-11 14:52
Tx date 2022-05-11 		$ASP
Acerus Pharmaceuticals Corporation 		Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$900.00
+200 vol
$4.50 each 		2,306
Filed 2022-05-11 14:52
Tx date 2022-05-11 		$ASP
Acerus Pharmaceuticals Corporation 		Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$440.00
+100 vol
$4.40 each 		2,106
Filed 2022-05-06 16:03
Tx date 2022-05-06 		$ASP
Acerus Pharmaceuticals Corporation 		Chabursky, Borys
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-2,158,445 vol 		10,846
Filed 2022-05-06 16:02
Tx date 2022-05-06 		$ASP
Acerus Pharmaceuticals Corporation 		Chabursky, Borys
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-485,013 vol 		2,437
Filed 2022-03-17 15:29
Tx date 2022-03-16 		$ASP
Acerus Pharmaceuticals Corporation 		Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+3,961,218 vol 		15,796,540
Filed 2022-03-17 15:28
Tx date 2022-03-16 		$ASP
Acerus Pharmaceuticals Corporation 		Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-3,961,218 vol 		0
Filed 2022-03-11 19:14
Tx date 2022-03-11 		$ASP
Acerus Pharmaceuticals Corporation 		Leckie, William Scott
4 - Director of Issuer
Holder: 7th Merchant Corp (Indirect Ownership)
Common Shares
97 - Other
+927,092 vol 		927,092
Filed 2022-03-11 19:12
Tx date 2020-06-23 		$ASP
Acerus Pharmaceuticals Corporation 		Leckie, William Scott
4 - Director of Issuer
Holder: 7th Merchant Corp (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-11 19:11
Tx date 2022-03-11 		$ASP
Acerus Pharmaceuticals Corporation 		Leckie, William Scott
4 - Director of Issuer
Holder: 1680897 Ontario (Indirect Ownership)
Common Shares
97 - Other
-927,092 vol 		0